Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amiodarone or Verapamil in COVID-19
NCT04351763Phase 3Completed
- Sponsor
- Nicolaus Copernicus University
- Start
- May 2020
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amiodarone, verapamil in coronavirus disease 2019 (COVID-19), sponsored by Nicolaus Copernicus University. Started May 2020; status: completed.
02
Drugs
amiodaroneverapamil
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04351763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04351763.